Condition
Recurrent Vulvar Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Recurrent Vulvar Cancer clinical trials that are recruiting, at sites in 2 countries (most in Germany (1), Poland (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer (REGYNERA-tion) Registry
This registry tests how reirradiation and total ablative strategies are used in real-world care for adults with recurrent gynecologic cancers and tracks outcomes to see what happens after these treatments.
-
Pembrolizumab plus lenvatinib for recurrent or advanced vulvar cancer
This study will try pembrolizumab plus lenvatinib for people with recurrent, persistent, metastatic, or locally advanced vulvar cancer that cannot be cured with surgery or radiotherapy.
Related topics
Quick answers
How many Recurrent Vulvar Cancer clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Germany (1 trial), Poland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.